A depression drug that works after two doses will make daily antidepressants obsolete
Your call? One tap, no sign-up
Helus Pharma reported results for HLP003, given as an add-on to people already on antidepressants. In its APPROACH trial it beat placebo by 7.6 points on the MADRS depression scale at week 6, with improvement starting by day 2 and a 56% response rate. The stock dropped hard pre-market because of three serious events in the treatment arm, then bounced. People on X are already calling it the end of taking a pill every day for years. Others point out it was tested on top of antidepressants, not instead of them, there's a second trial still to come, and approval wouldn't be before 2028 at the earliest. Game changer, or way too early?
more βWhat the receipts say: No receipts Official sources never set the Bro-Meter.